More Intellectual Property Articles

Life Sciences

Life Sciences: Protecting the Crown Jewels - Important Strategies for Licensors of Intellectual Property

An innovator or owner of patent rights or other technology in the life sciences arena is often unable, because of lack of financial or other resources, to develop or commercialize a pharmaceutical product covered by such intellectual property rights. In these cases, the innovator/owner (the...

Read More

Appellate Law

Tackling Teva and More at the U.S. Supreme Court

MCC: On January 20, 2015, the U.S. Supreme Court issued its opinion in the closely watched Teva Pharmaceuticals v. Sandoz case. Can you give us some background on the case and talk about what was at stake and what was decided? Dragseth: Teva had sued Sandoz on its patent covering a method for...

Read More

Intellectual Property

Copyright Disputes in the Digital Age

Editor: Please summarize the legal issues pertaining to copyright infringement claims arising from work that a plaintiff alleges was accessed via the Internet. Faber: In order to prevail on a claim for copyright infringement, a plaintiff must establish both ownership of a valid copyright and...

Read More